6.24

0.48% 0.03

Optimizerx Corp (OPRX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Optimizerx Corp stock is traded at $6.24, with a volume of 195.01K. It is up +0.48% in the last 24 hours and up +31.65% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

Previous Close:

$6.21

Open:

$6.23

24h Volume:

195.01K

Relative Volume:

0.44

Market Cap:

$117.09M

Revenue:

$107.35M

Net Income/Loss:

$6.84M

P/E Ratio:

17.67

EPS:

0.3532

Net Cash Flow:

$14.64M

1W Performance:

-6.73%

1M Performance:

+31.65%

6M Performance:

-47.65%

1Y Performance:

-55.24%

1-Day Range:

$6.18

$6.3151

1-Week Range:

$6.13

$6.68

52-Week Range:

$4.54

$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name

Optimizerx Corp

Sector

Healthcare (1071)

Industry

Health Information Services (47)

Phone

248-651-6558

Address

260 CHARLES STREET, WALTHAM, MI

Employee

105

Twitter

@OpRxTweets

Next Earnings Date

2026-08-06

Latest SEC Filings

OPRX's Discussions on Twitter

Compare OPRX vs VEEV, BTSG, HQY, TEM, TXG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPRX Optimizerx Corp	6.24	117.09M	107.35M	6.84M	14.64M	0.3532
VEEV Veeva Systems Inc	186.24	30.25B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	72.91	14.31B	13.65B	169.86M	412.12M	1.0758
HQY Healthequity Inc	94.64	7.91B	1.34B	230.70M	440.96M	2.6695
TEM Tempus Ai Inc	42.69	7.69B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	46.27	5.87B	638.78M	-22.66M	122.18M	-0.1744

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Dec-20-24	Initiated	Stephens	Equal-Weight
Jul-25-24	Resumed	B. Riley Securities	Buy
Apr-04-24	Initiated	JMP Securities	Mkt Outperform
Jan-03-24	Initiated	Barclays	Equal Weight
Feb-02-23	Resumed	B. Riley Securities	Buy
Nov-01-22	Initiated	Stifel	Buy
Jul-15-22	Initiated	SVB Leerink	Outperform
Oct-18-21	Resumed	B. Riley Securities	Buy
Apr-13-21	Initiated	RBC Capital Mkts	Outperform
Jan-03-19	Initiated	William Blair	Outperform

View All

Optimizerx Corp Stock (OPRX) Latest News

Jul 23, 2026

OptimizeRx appoints Sarah Bast as chief marketing officer - Investing.com

Jul 23, 2026

OptimizeRx appoints Sarah Bast as chief marketing officer By Investing.com - Investing.com Canada

Jul 23, 2026

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer - The Manila Times

Jul 23, 2026

Press Release: OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer - Moomoo

Jul 23, 2026

Jul 22, 2026

Royce & Associates (OPRX) discloses 1.09M-share passive stake in OptimizeRx - Stock Titan

Jul 22, 2026

Jul 16, 2026

OptimizeRx Corp. Hits New 52-Week Low at $4.54 Amid Market Struggles - MarketsMojo

Jul 01, 2026

Jun 30, 2026

OptimizeRx stock rises after launching CopayCue product By Investing.com - Investing.com South Africa

Jun 30, 2026

OptimizeRx stock rises after launching CopayCue product - Investing.com

Jun 30, 2026

OptimizeRx launches CopayCue for prescription savings - Investing.com

Jun 30, 2026

OptimizeRx launches CopayCue for prescription savings By Investing.com - Investing.com Nigeria

Jun 30, 2026

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent - The Manila Times

Jun 30, 2026

OptimizeRx Launches CopayCue to Deliver Brand Savings Offers at the Point of Prescribing - Quiver Quantitative

Jun 30, 2026

OptimizeRx ties copay offers to physician intent at prescribing moment - Stock Titan

Jun 30, 2026

OptimizeRx Corporation (OPRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jun 30, 2026

Jun 29, 2026

Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch By Investing.com - Investing.com South Africa

Jun 29, 2026

OptimizeRx stock rating maintained at Market Outperform by Citizens - Investing.com Nigeria

Jun 29, 2026

Jun 28, 2026

OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Dynamic Index - marketscreener.com

Jun 28, 2026

Jun 26, 2026